755 related articles for article (PubMed ID: 16133491)
21. Role of endothelium/nitric oxide in atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
Brawley L; Shaw AM; MacDonald A
Eur J Pharmacol; 2000 Jun; 398(2):285-96. PubMed ID: 10854841
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological properties of β-adrenoceptors mediating rat superior mesenteric artery relaxation and the effects of chemical sympathetic denervation.
Obara K; Shigematsu M; Takahasi H; Iiboshi Y; Yoshioka K; Kasuya Y; Tanaka Y
Life Sci; 2020 Jan; 241():117155. PubMed ID: 31837330
[TBL] [Abstract][Full Text] [Related]
23. Beta-adrenergic responses are significantly enhanced in rat carotid artery with intimal hyperplasia.
Heijenbrok FJ; Mathy MJ; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):276-83. PubMed ID: 10997730
[TBL] [Abstract][Full Text] [Related]
24. Beta1- and beta3-adrenoceptors mediate relaxation in ovine trachealis smooth muscle.
Mustafa SM; Yousif M; Cherian A; Oriowo MA
J Auton Pharmacol; 1999 Aug; 19(4):193-9. PubMed ID: 10589969
[TBL] [Abstract][Full Text] [Related]
25. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
26. Role of potassium channels and nitric oxide in the relaxant effects elicited by beta-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat.
Dumas JP; Goirand F; Bardou M; Dumas M; Rochette L; Advenier C; Giudicelli JF
Br J Pharmacol; 1999 May; 127(2):421-8. PubMed ID: 10385242
[TBL] [Abstract][Full Text] [Related]
27. Isoproterenol amplifies 17 beta-estradiol-mediated vasorelaxation: role of endothelium/nitric oxide and cyclic AMP.
Chan HY; Yao X; Tsang SY; Bourreau JP; Chan FL; Huang Y
Cardiovasc Res; 2002 Feb; 53(3):627-33. PubMed ID: 11861033
[TBL] [Abstract][Full Text] [Related]
28. Influence of beta-adrenoceptor agonists on the pulmonary circulation. Effects of a beta3-adrenoceptor antagonist, SR 59230A.
Dumas M; Dumas JP; Bardou M; Rochette L; Advenier C; Giudicelli JF
Eur J Pharmacol; 1998 May; 348(2-3):223-8. PubMed ID: 9652337
[TBL] [Abstract][Full Text] [Related]
29. Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries.
Kozłowska H; Schlicker E; Kozłowski M; Siedlecka U; Laudański J; Malinowska B
J Cardiovasc Pharmacol; 2005 Jul; 46(1):76-82. PubMed ID: 15965358
[TBL] [Abstract][Full Text] [Related]
30. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
Salie R; Moolman JA; Lochner A
Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of beta3-adrenoceptor-mediated relaxation in intact and endotoxin-treated equine digital veins.
Mallem MY; Gogny M; Gautier F; Bucas V; Desfontis JC
Am J Vet Res; 2003 Jun; 64(6):708-14. PubMed ID: 12828256
[TBL] [Abstract][Full Text] [Related]
32. Effect of β
Saunders SL; Hutchinson DS; Britton FC; Liu L; Markus I; Sandow SL; Murphy TV
Br J Pharmacol; 2021 Apr; 178(8):1789-1804. PubMed ID: 33506492
[TBL] [Abstract][Full Text] [Related]
33. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
Toyoshima H; Nasa Y; Hashizume Y; Koseki Y; Isayama Y; Kohsaka Y; Yamada T; Takeo S
J Cardiovasc Pharmacol; 1998 Oct; 32(4):543-51. PubMed ID: 9781922
[TBL] [Abstract][Full Text] [Related]
34. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
35. Characterization of beta-adrenoceptor mediated smooth muscle relaxation and the detection of mRNA for beta1-, beta2- and beta3-adrenoceptors in rat ileum.
Roberts SJ; Papaioannou M; Evans BA; Summers RJ
Br J Pharmacol; 1999 Jun; 127(4):949-61. PubMed ID: 10433503
[TBL] [Abstract][Full Text] [Related]
36. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro.
Ferro A; Queen LR; Priest RM; Xu B; Ritter JM; Poston L; Ward JP
Br J Pharmacol; 1999 Apr; 126(8):1872-80. PubMed ID: 10372832
[TBL] [Abstract][Full Text] [Related]
37. Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.
Rozec B; Quang TT; Noireaud J; Gauthier C
Br J Pharmacol; 2006 Apr; 147(7):699-706. PubMed ID: 16474420
[TBL] [Abstract][Full Text] [Related]
38. Role of beta1-, beta2-, and beta3-adrenoceptors in contractile hypersensitivity in a model of small bowel transplantation.
Rickenbacher A; Seiler R; Honegger U; Shaw SG; Balsiger BM
Surgery; 2008 Jan; 143(1):94-102. PubMed ID: 18154937
[TBL] [Abstract][Full Text] [Related]
39. β-adrenergic Receptor Blocker ICI 118,551 Selectively Increases Intermediate-Conductance Calcium-Activated Potassium Channel (IK
Ozkan MH; Uma S
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):570-576. PubMed ID: 29278444
[TBL] [Abstract][Full Text] [Related]
40. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
Wang XS; Lau HY
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
